NEWARK, N.J., June 6, 2023 /PRNewswire/ — BioCentriq®, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy announced today that it has expanded its partnership with Kytopen, a Cambridge based startup spun out of Massachusetts Institute of Technology (MIT). The partnership was originally announced in March of…Read More
BioCentriq and Kytopen Expand Partnership to Expedite Impact of Transformative GeneEditing Technology on Cell Therapy Manufacturing
